BIA Separations Slovenia Raises EUR 1.5 Million from META Ingenium
News Sep 23, 2015
BIA Separations Slovenia has raised 1,5M EUR from META Ingenium managed by Luigi Amati and Nina Mazgan in order to expand the business to food industry and strengthen its balance sheet. The said investment will support growing interest in BIA Separations 40L and larger CIM monolithic columns.
According to Ales Strancar, executive director of BIA Separations Slovenia, the said investment will enable the Company to address the food industry needs without compromising the support of exponentially growing number of Company projects in the field of Gene Therapy.
“BIA Separations Austria, the largest shareholder of BIA Separations Slovenia, moved away from daily business of BIA Separations Slovenia and is undergoing financial restructuring to prepare for a targeted strategic alliance. We welcome Meta Ingenium and its expertise on board of BIA Separations Slovenia. The Company achieved exceptional growth and the Meta investment strengthens the Company to stay on track with all the requests” said Emmerich Zoechbauer, Chair of the Board of BIA Separations Austria and non-executive director of BIA Separations Slovenia.
“BIA Separations Slovenia has leading edge technology and significant growth potential. We are happy to support the Company with our expertise and the capital“ said Michele Marzola, representative of the Meta group, experienced private investor in 27 companies, former Vice-President & General Manager of the IBM Global Services acting now as non-executive director of BIA Separations Slovenia also.
Simple Water Test Could Prevent Crippling Bone DiseaseNews
A simple colour-changing test to detect fluoride in drinking water, could in the future prevent the crippling bone disease, skeletal fluorosis, in developing countries such as India and Tanzania.READ MORE
Allergy Amplifier Implicated in Asthma Also Intensifies Food AllergyNews
Scientist who previously reported that a small protein, aptly named histamine-releasing factor, played a pro-inflammatory role in asthma have now shown that it also serves as a “food allergy amplifier”. This work paves the way for blood tests to predict which patients will respond to allergy therapy, and strongly supports the idea that drugs designed to block HRF could prevent food allergy attacks.READ MORE
Study Finds Dietary Levels of Genistein May Adversely Affect Female FertilityNews
Researchers have found that chronic preconception exposure to genistein, a chemical found in soy foods and some dietary supplements, affected pregnancy rates in mice and was associated with prolonged labor, smaller litters and pups, and higher rates of pup mortality,READ MORE